Simulands: Human Grade Portable Simulators to Revolutionize Cardiovascular Device Development and Clinical Training

Problem

Due to the complexity of the cardiovascular system and limitation of animal models, the use of simulators for training and education is growing. Existing computational and silicone simulators have substantial limitations:

Opportunity

Simulands provides Academia and Industry a range of customized platforms for development and training of cardiovascular therapies. Our mission is to replace training on animals and patients, with simple and portable Human Grade Simulators. Simulands integrates both physicians and industry needs during simulator design, with imaging-guidance and high-fidelity capabilities. These platforms are ideal to overcoming the market entry challenges of new technologies.

Simulands Products

Simulands simulators are suitable for design validation studies and training sessions. Assessing the performance of a device in a standardized setting with CT-scan based cardiac anatomy and hydrodynamics, allows to closely assess the device functionality and operability. Whether to assess device performance or to train users or imagers, Simulands platforms provide tools for realistic and significant experiences.

Medical Significance

Simulands will revolutionize clinical practice by allowing device developers and users to improve their product, enhancing procedural performance and reducing human factor elements. This lowers the risks further down the preclinical and clinical path, allowing physicians and industry to provide safe and high-quality procedures for patients.

Target Markets

Simulands simulators will revolutionize cardiac surgery and interventions with a new concept: Good Simulation Practice (GSP) . Standardized and evidence based criteria for therapy development, operator training and procedural certification principles are applied. With the exponential growth of structural heart therapies, Academia and Hospitals will adopt Simulands products to create translational training labs and offer all tools and steps for achieving adequate competence and skills before the bedside.

Team

Francesco Maisano: Head of Cardiovascular Surgery at the Zurich University Hospital. Innovator

Monica Tocchi: Cardiologist, Regulatory KOL, with broad experience in leading strategic and regulatory MedTech pathways

Andrea Guidotti: R&D, preclinical models and therapy development expert

Amir Gross: Serial entrepreneur, Innovator and business expert.

Simulands Video Pitch